$9.29 Million is the total value of Founders Fund VI Management, LLC's 2 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ROIVANT SCIENCES LTD | $8,944,717 | +148.2% | 1,119,489 | 0.0% | 96.26% | +17.7% | ||
AMTI | Buy | APPLIED MOLECULAR TRANS INC | $347,175 | -56.7% | 826,607 | +153.1% | 3.74% | -79.5% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ROIVANT SCIENCES LTD | 8 | Q3 2023 | 99.0% |
APPLIED MOLECULAR TRANS INC | 8 | Q3 2023 | 34.0% |
SNAP INC | 4 | Q2 2023 | 9.8% |
OSCAR HEALTH INC | 2 | Q1 2022 | 79.6% |
View Founders Fund VI Management, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
View Founders Fund VI Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.